These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17168676)

  • 1. Anti-invasive/anti-metastasis strategies: new roads, new tools and new hopes.
    Dollé L; Depypere HT; Bracke ME
    Curr Cancer Drug Targets; 2006 Dec; 6(8):729-51. PubMed ID: 17168676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.
    Kauffman EC; Robinson VL; Stadler WM; Sokoloff MH; Rinker-Schaeffer CW
    J Urol; 2003 Mar; 169(3):1122-33. PubMed ID: 12576866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targets in the discovery and development of novel antimetastatic agents: current progress and future prospects.
    Wong MS; Sidik SM; Mahmud R; Stanslas J
    Clin Exp Pharmacol Physiol; 2013 May; 40(5):307-19. PubMed ID: 23534409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives of Plant Natural Products in Inhibition of Cancer Invasion and Metastasis by Regulating Multiple Signaling Pathways.
    Sarwar MS; Zhang HJ; Tsang SW
    Curr Med Chem; 2018; 25(38):5057-5087. PubMed ID: 28925869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical targets for anti-metastasis therapy.
    Chambers AF; MacDonald IC; Schmidt EE; Morris VL; Groom AC
    Adv Cancer Res; 2000; 79():91-121. PubMed ID: 10818678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis.
    Uekita T; Sakai R
    Cancer Sci; 2011 Nov; 102(11):1943-8. PubMed ID: 21812858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cytoskeleton reorganisation as antimetastatic treatment.
    Quintela-Fandino M; González-Martín A; Colomer R
    Clin Transl Oncol; 2010 Oct; 12(10):662-9. PubMed ID: 20947480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine receptor kinase B silencing inhibits anoikis‑resistance and improves anticancer efficiency of sorafenib in human renal cancer cells.
    Zhang P; Xing Z; Li X; Song Y; Zhao J; Xiao Y; Xing Y
    Int J Oncol; 2016 Apr; 48(4):1417-25. PubMed ID: 26820170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Mechanisms of Breast Cancer Metastasis and Potential Anti-metastatic Compounds.
    Tungsukruthai S; Petpiroon N; Chanvorachote P
    Anticancer Res; 2018 May; 38(5):2607-2618. PubMed ID: 29715080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key questions in metastasis: new insights in molecular pathways and therapeutic implications.
    Gueron G; De Siervi A; Vazquez E
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1867-80. PubMed ID: 21470130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [NM23 and metastasis suppressor genes: update].
    Boissan M; Poupon MF; Lacombe ML
    Med Sci (Paris); 2007 Dec; 23(12):1115-23. PubMed ID: 18154714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion.
    Zheng H; Li Y; Wang Y; Zhao H; Zhang J; Chai H; Tang T; Yue J; Guo AM; Yang J
    Toxicol Appl Pharmacol; 2014 Oct; 280(1):10-20. PubMed ID: 25094029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural products as anti-invasive and anti-metastatic agents.
    Jiang YL; Liu ZP
    Curr Med Chem; 2011; 18(6):808-29. PubMed ID: 21182481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy.
    Iiizumi M; Liu W; Pai SK; Furuta E; Watabe K
    Biochim Biophys Acta; 2008 Dec; 1786(2):87-104. PubMed ID: 18692117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future approaches for the therapeutic targeting of metastasis (review).
    Germanov E; Berman JN; Guernsey DL
    Int J Mol Med; 2006 Dec; 18(6):1025-36. PubMed ID: 17089005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation.
    Kim JY; Lee N; Kim YJ; Cho Y; An H; Oh E; Cho TM; Sung D; Seo JH
    Cancer Lett; 2017 Feb; 386():151-160. PubMed ID: 27894956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metastatic process: methodological advances and pharmacological challenges.
    Mazzocca A; Carloni V
    Curr Med Chem; 2009; 16(14):1704-17. PubMed ID: 19442141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Ionone and its analogs as promising anticancer agents.
    Ansari M; Emami S
    Eur J Med Chem; 2016 Nov; 123():141-154. PubMed ID: 27474930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Synthetic β-Nitrostyrene Derivative CYT-Rx20 Inhibits Esophageal Tumor Growth and Metastasis via PI3K/AKT and STAT3 Pathways.
    Chiu WC; Lee YC; Su YH; Wang YY; Tsai CH; Hou YA; Wang CH; Huang YF; Huang CJ; Chou SH; Hsieh PW; Yuan SF
    PLoS One; 2016; 11(11):e0166453. PubMed ID: 27875549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
    Abdollahi A; Folkman J
    Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.